APA (7th ed.) Citation

M, L., NA, B., MC, G., M, F., BW, D., BW, S., & PA, T. (2024). ATR inhibition using gartisertib enhances cell death and synergises with temozolomide and radiation in patient-derived glioblastoma cell lines. Oncotarget, 15, 1. https://doi.org/10.18632/oncotarget.28551

Chicago Style (17th ed.) Citation

M, Lozinski, Bowden NA, Graves MC, Fay M, Day BW, Stringer BW, and Tooney PA. "ATR Inhibition Using Gartisertib Enhances Cell Death and Synergises with Temozolomide and Radiation in Patient-derived Glioblastoma Cell Lines." Oncotarget 15 (2024): 1. https://doi.org/10.18632/oncotarget.28551.

MLA (9th ed.) Citation

M, Lozinski, et al. "ATR Inhibition Using Gartisertib Enhances Cell Death and Synergises with Temozolomide and Radiation in Patient-derived Glioblastoma Cell Lines." Oncotarget, vol. 15, 2024, p. 1, https://doi.org/10.18632/oncotarget.28551.